Hepatitis B drug approval marks a significant milestone in treatment options for patients, offering hope and proven efficacy.
Month: October 2026
Cancer drug price update: NPPA caps margins at 30%
Cancer drug price update reveals NPPA’s new margin caps for 137 medicines effective November 9.
Korean obesity drug Offers Smart Choice Against Mounjaro
Korean obesity drug is here to challenge Mounjaro with a slimmer price tag and effective results.
FDA Approval of WELTRUZA: A Proven Solution for Patients
FDA approval of WELTRUZA marks a significant advancement in treatment options.
Lipocine stock surge: Is it the best investment now?
Lipocine stock surge is making waves after Health Canada approval. What does this mean for investors?
Drug price gaps: The Worst Proven Mark-ups Revealed
Drug price gaps are alarming, with some medicines marked up over 50 times. Discover the implications for consumers.